Lonza News Jan 28, 2026 Lonza still intends to sell its capsules and health ingredients business - Endpoints News
Lonza News Jan 28, 2026 Earnings call transcript: Lonza reports strong 2025 results, stock dips - Investing.com
Lonza News Jan 28, 2026 Switzerland's Lonza edges closer to sale of its capsule and health ingredients business - Reuters
Lonza News Jan 28, 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - Reuters
Lonza News Jan 28, 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - wkzo.com
Lonza News Jan 28, 2026 Lonza forecasts 2026 sales growth of 11-12% for core CDMO business - Global Banking & Finance Review
Lonza News Jan 28, 2026 Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration - TradingView
Lonza News Jan 26, 2026 Lonza Group AG (LONN.SW, SIX): CHF550.20 intraday ahead of 28 Jan earnings — what to watch - Meyka